NCT04206540

Brief Summary

The vagus nerve is a largely-internal nerve that controls many bodily functions, including stomach function. Investigators hope that electrically stimulating the nerve around the external ear will also stimulate the internal vagus nerve. If it does, then investigators hope that this will help the treatment of patients with nausea and vomiting and disordered stomach function. Investigators also hope to be able to measure the activity of the vagus nerve when it is stimulated in other ways. This could help investigators learn more about studying this nerve in the future.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
16mo left

Started Jul 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
Jul 2019Aug 2027

Study Start

First participant enrolled

July 22, 2019

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

December 18, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 20, 2019

Completed
6.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2027

Last Updated

March 6, 2026

Status Verified

March 1, 2026

Enrollment Period

7.1 years

First QC Date

December 18, 2019

Last Update Submit

March 4, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Amplitude of the Vagus nerve with ABVN

    measure the amplitude of vagal nerve compound action potentials in healthy volunteers with skin electrodes over right and left vagus nerve during ABVN stimulation

    3 years

  • Amplitude of Vagus Nerve with Vagal Maneuvers

    measure the amplitude of vagal nerve compound action potentials in healthy volunteers with skin electrodes over right and left vagus nerve during Vagal Maneuvers.

    3 years

Secondary Outcomes (2)

  • EGG and ABVN

    3 years

  • EGG and Vagal maneuver

    3 years

Study Arms (1)

Healthy Subjects

EXPERIMENTAL

Healthy volunteers aged 18-80 years old who will undergo vagus nerve stimulation.

Device: Transcutaneous Auricular Vagus Nerve StimulationProcedure: Vagal Stimulation

Interventions

Electrical stimulation of the vagus nerve around the external ear using a transcutaneous device. Electrical current will be increased in intensity based on subject feedback of a scale 0-10. Electrical stimulation will be delivered for 2 minutes once the subject reports the maximum comfortable intensity.

Also known as: ML1101 Stimulus Isolator
Healthy Subjects

Subjects will be asked to do the following in order to stimulate the vagus nerve: * Cough 6 to 8 forceful coughs * Have an ice cold wash cloth placed on their face for 10 seconds. * Carotid massage * Gagging: a tongue depressor is briefly inserted into the back of the mouth touching the bag of the throat. * Valsalva maneuver: Subjects will be asked to bear down as if having a bowel movement. They will be asked to blow through a mouthpiece that is hooked to a device that measures how hard they are blowing. Alternatively, we can have them blow through the barrel of a 10 ml syringe for 15-20 seconds. * Eating: Subjects will be asked to drink water and/or Ensure that has 220 calories after fasting overnight.

Also known as: Vagal Maneuvers
Healthy Subjects

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy volunteers
  • Aged 18-80 years
  • Willing to have electrodes placed in the external ear (ABVN arm)
  • Willing to perform vagal activity maneuver ( Vagal arm)

You may not qualify if:

  • Unable to provide consent
  • Having gastric motility issues as determined by the PI or Sub I
  • Taking medications affecting gastric motility
  • Pregnant females
  • Prisoners

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Indiana University Hosptial

Indianapolis, Indiana, 46202, United States

Location

MeSH Terms

Interventions

Vagus Nerve Stimulation

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeutics

Study Officials

  • Thomas V Nowak, MD

    Indiana University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor and Principal Investigator

Study Record Dates

First Submitted

December 18, 2019

First Posted

December 20, 2019

Study Start

July 22, 2019

Primary Completion (Estimated)

August 31, 2026

Study Completion (Estimated)

August 31, 2027

Last Updated

March 6, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations